Advances in engineering immune proteins as therapeutics. // Current Opinion in Biomedical Engineering. – URL: https://www.sciencedirect.com/science/article/pii/S2468451126000371?dgcid=rss_sd_all
Advances in engineering immune proteins as therapeutics. Current Opinion in Biomedical Engineering. https://www.sciencedirect.com/science/article/pii/S2468451126000371?dgcid=rss_sd_all
“Advances in engineering immune proteins as therapeutics.” Current Opinion in Biomedical Engineering.
@article{article42455,
title = {Advances in engineering immune proteins as therapeutics},
journal = {Current Opinion in Biomedical Engineering},
url = {https://www.sciencedirect.com/science/article/pii/S2468451126000371?dgcid=rss_sd_all}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...